Adenosine inhibits neutrophil degranulation in activated human whole blood: Involvement of adenosine A2 and A3 receptors

Journal of Immunology

Volumn 158, Issue 11, 1997, Pages 5400-5408

  Bouma, Maarten G ^a   Jeunhomme, Trudi M M A ^a   Boyle, David L ^b   Dentener, Mieke A ^a   Voitenok, Nikolai N ^c   Van Den Wildenberg, Frans A J M ^a   Buurman, Wim A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Fund Fundamental Studs Rep Belarus   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR;

ARTICLE; DRUG EFFECT; HUMAN; IMMUNOLOGY; LEUKOCYTE ACTIVATION; NEUTROPHIL;

ADENOSINE; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, PURINERGIC P1;

EID: 0031156985     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Henson, P. M., J. E. Henson, C. Fittschen, D. L. Bratton, and D. W. H. Riches. 1992. Degranulation and secretion by phagocytic cells. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 511.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457.
3. Welbourn, C. R. B., G. Goldman, I. S. Paterson, C. R. Valeri, D. Shepro, and H. B. Hechtman. 1991. Pathophysiology of ischaemia-reperfusion injury: central role of the neutrophil. Br. J. Surg. 78:651.
4. -) release by activated human neutrophils. Clin. Immunol. Immunopathol. 42:76.
5. Cronstein, B. N., M. A. Eberle, H. E. Gruber, and R. I. Levin. 1991. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. USA 88:2441.
6. Firestein, G. S., D. A. Bullough, M. D. Erion, R. Jimenez, M. Ramirez-Weinhouse, J. Barankiewicz, C. W. Smith, H. E. Gruber, and K. M. Mullane. 1995. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins. J. Immunol. 154:326.
7. 2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J. Immunol. 155:2579.
8. Cronstein, B. N., R. I. Levin, J. Belanoff, G. Weissmann, and R. Hirschhorn. 1986. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78:760.
9. 2 receptor on human neutrophils. J. Immunol. 135:1366.
10. 2 receptors. J. Immunol. 148:2201.
11. Newby, A. C. 1984. Adenosine and the concept of retaliatory metabolites. Trends Biochem. Sci. 9:42.
12. Mullane, K., D. Bullough, and D. Shapiro. 1993. From academic vision to clinical reality: a case study of aeadesine. Trends Cardiovasc. Med. 3:227.
13. Gruber, H. E., M. E. Hoffer, D. R. McAllister, P. K. Laikind, T. A. Lane, G. W. Schmid-Schoenbein, and R. L. Engler. 1989. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes, and injury. Circulation 80:1400.
14. Vinten-Johansen, J., K. Nakanishi, Z. Q. Zhao, D. S. McGee, and P. Tan. 1993. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts. Circulation 88:350.
15. Sandhu, G. S., A. C. Burrier, and D. R. Janero. 1993. Adenosine deaminase inhibitors attenuate ischemic injury and preserve energy balance in isolated guinea pig heart. Am. J. Physiol 265:H1249.
16. Parmely, M. J., W. W. Zhou, C. K. Edwards III, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389.
17. Firestein, G. S., D. Boyle, D. A. Bullough, H. E. Gruber, F. G. Sajjadi, A. Montag, B. Sambol, and K. M. Mullane. 1994. Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol. 152:5853.
18. Collis, M. G., and S. M. O. Hourani. 1993. Adenosine receptor subtypes. Trends Pharmacol. Sci. 14:360.